Rheumatoid arthritis: A risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis

Journal of Orthopaedic Science

Volumn 15, Issue 1, 2010, Pages 57-63

  Niki, Yasuo ^a,b   Matsumoto, Hideo ^a   Hakozaki, Akihiro ^a   Mochizuki, Takeshi ^b   Momohara, Shigeki ^b  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; ETANERCEPT; HEPARIN; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; KNEE; KNEE OSTEOARTHRITIS; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RHEUMATOID ARTHRITIS; RISK FACTOR; SURGICAL RISK; SYMPTOM; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 77249108019     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-009-1410-3     Document Type: Article

References (32)

1. W.H. Geerts G.F. Pineo J.A. Heit D. Bergqvist M.R. Lassen C.W. Colwell, et al. 2004 Prevention of thromboembolism Chest 126 suppl 338S 400S 10.1378/chest.126.3-suppl.338S 15383478 1:CAS:528:DC%2BD2cXptV2msbw%3D (Pubitemid 39302602)
2. S. Fujita S. Hirota T. Oda Y. Kato Y. Tsukamoto T. Fuji 2000 Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan Clin Orthop 375 168 174 10.1097/00003086-200006000-00020 10853166
3. M.W. Russel D.C.A. Taylor G. Cumminus D.M. Huse 2002 Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients Am J Manag Care 8 S3 S9
4. L.M. Coussens Z. Werb 2002 Inflammation and cancer Nature 420 860 867 10.1038/nature01322 12490959 1:CAS:528:DC%2BD38XpsFygtb4%3D (Pubitemid 36019639)
5. B.B. Aggarwal S. Shishodia S.K. Sandur M.K. Pandey G. Sethi 2006 Inflammation and cancer: how hot is the link? Biochem Pharmacol 72 1605 1621 10.1016/j.bcp.2006.06.029 16889756 1:CAS:528:DC%2BD28XhtFOjt77E (Pubitemid 44666739)
6. C.A. Solem E.V. Loftus W.J. Tremaine W.J. Sandborn 2004 Venous thromboembolism in inflammatory bowel disease Am J Gastroenterol 99 97 101 10.1046/j.1572-0241.2003.04026.x 14687149 (Pubitemid 38679109)
7. C.N. Bernstein J.F. Blanchard D.S. Houston A. Wajda 2001 The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a populationbased cohort study Thromb Haemost 85 430 434 11307809 1:CAS:528:DC%2BD3MXis1yhsLc%3D
8. S.J. Van Deventer H.R. Buller J.W. ten Cate L.A. Aarden C.E. Hack A. Sturk 1990 Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways Blood 76 2520 2526 2124934
9. P. Psuja M. Zozulinska Z. Turowiecka W. Cieslikowski H. Vinazzer K. Zawilska 2002 Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock Clin Appl Thromb Hemost 8 225 230 10.1177/107602960200800305 12361199 1:CAS:528:DC%2BD38Xot1Wrt7o%3D
10. A.K. So P.A. Varisco B. Kemkes-Matthes C. Herkenne-Morard V. Chobaz-Peclat J.C. Gerster, et al. 2003 Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways J Thromb Haemost 1 2510 2515 10.1111/j.1538-7836.2003.00462.x 14675085 1:CAS:528: DC%2BD2cXktFOlsLk%3D
11. B. Seriolo S. Accardo A. Garnero D. Fasciolo M. Cutolo 1999 Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patients Rheumatology (Oxford) 38 675 678 10.1093/rheumatology/38.7.675 1:CAS:528:DyaK1MXlsFegt70%3D (Pubitemid 29507339)
12. B. Seriolo S. Accardo D. Fasciolo S. Bertolini M. Cutolo 1996 Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis Clin Exp Rheumatol 14 593 599 8978952 1:STN:280:DyaK2s7jtlGmtQ%3D%3D
13. J.G. Fort F.S. Cowchock J.L. Abruzzo J.B. Smith 1987 Anticardiolipin antibodies in patients with rheumatic diseases Arthritis Rheum 30 752 760 10.1002/art.1780300705 3619960 1:STN:280:DyaL2s3pvVKntQ%3D%3D
14. R.R. Buchanan G. Kraag 1980 Is there a lower incidence of deep venous thrombosis after joint replacement in rheumatoid arthritis? J Rheumatol 7 551 554 7420338 1:STN:280:DyaL3M%2Fisl2qtA%3D%3D
15. J.M. Sikorski W.G. Hampson G.E. Staddon 1981 The natural history and aetiology of deep vein thrombosis after total hip replacement J Bone Joint Surg Br 63 171 177 7217137
16. H.A. Van Heereveld R.F. Laan F.H. van den Hoogen M.C. Malefijt I.R. Novakova L.B. van de Putte 2001 Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement Ann Rheum Dis 60 974 976 10.1136/ard.60.10.974 11557656 (Pubitemid 32885674)
17. C.W. Colwell Jr S.D. Berkowitz J.R. Lieberman P.C. Comp J.S. Ginsberg G. Paiement, et al. 2005 Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty J Bone Joint Surg Am 87 2169 2177 10.2106/JBJS.D.02184 16203879 (Pubitemid 41407539)
18. Salzman EW, Hirsh J. The epidemiology, pathogenesis and natural history of venous thrombosis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott; 1994. p. 1275-1296.
19. L.V. Rao S.I. Rapaport S.P. Bajaj 1986 Activation of human factor VII in the initiation of tissue factor-dependent coagulation Blood 68 685 691 3488776 1:CAS:528:DyaL28XlsFSms7o%3D
20. D.S. Fair M.J. MacDonald 1987 Cooperative interaction between factor VII and cell surface-expressed tissue factor J Biol Chem 262 11692 11698 3624232 1:CAS:528:DyaL2sXltlWrtrY%3D
21. N. Mackman 1996 Regulation of tissue factor gene expression in human monocytic and endothelial cells Haemostasis 26 suppl1 17 19 8904167 1:CAS:528:DyaK28XitlKktbc%3D
22. A. Bierhaus Y. Zhang Y. Deng N. Mackman P. Quehenberger M. Haase, et al. 1995 Mechanism of the tumor necrosis factor alphamediated induction of endothelial tissue factor J Biol Chem 270 26419 26432 10.1074/jbc.270.44.26419 7592857 1:CAS:528:DyaK2MXpt1eisLo%3D
23. E. Lindmark T. Tenno A. Siegbahn 2000 Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression Arterioscler Thromb Vasc Biol 20 2322 2328 11031222 1:CAS:528:DC%2BD3cXptVSis70%3D
24. C.T. Esmon 2005 The interactions between inflammation and coagulation Br J Haematol 131 417 430 10.1111/j.1365-2141.2005.05753.x 16281932 1:CAS:528:DC%2BD2MXhtlCisbnN (Pubitemid 43899639)
25. E.M. Conway R.D. Rosenberg 1988 Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells Mol Cell Biol 8 5588 5592 2854203 1:CAS:528:DyaL1MXjslGmsA%3D%3D
26. K. Fukudome C.T. Esmon 1994 Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor J Biol Chem 269 26486 26491 7929370 1:CAS:528:DyaK2cXmslensLk%3D (Pubitemid 24328474)
27. E.M. Scarpati J.E. Sadler 1989 Regulation of endothelial cell coagulant properties: modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor J Biol Chem 264 20705 20713 2555368 1:CAS:528:DyaL1MXmtFeju7Y%3D
28. R.N. Maini M. Elliott F.M. Brennan R.O. Williams M. Feldmann 1994 Targeting TNF alpha for the therapy of rheumatoid arthritis Clin Exp Rheumatol 12 suppl11 S63 S66 7768056
29. L.T. Kopeikina E.F. Kamper V. Koutsoukos Y. Bassiakos I. Stavridis 1997 Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity Clin Rheumatol 16 254 260 10.1007/BF02238960 9184262 1:STN:280: DyaK2szislGqtw%3D%3D (Pubitemid 27273171)
30. A. Vayá Y. Mira M. Martínez P. Villa F. Ferrando A. Estellés, et al. 2002 Biological risk factors for deep vein thrombosis Clin Hemorheol Microcirc 26 41 53 11904470
31. S. Banyai M. Banyai R. Koppensteiner 2002 Blood rheology in deep venous thrombosis: relation to persistent and transient risk factors Thromb Res 15 107
32. C. Gangireddy J.R. Rectenwald G.R. Upchurch T.W. Wakefield S. Khuri W.G. Henderson, et al. 2007 Risk factors and clinical impact of postoperative symptomatic venous thromboembolism J Vasc Surg 45 335 341 10.1016/j.jvs.2006.10. 034 17264013 (Pubitemid 46149995)